Loading
Profound Medical Corp. Stock: price and insider trades · United States
US·Mcap US$241.8M
No insider purchase over the last 90 days. The latest was filed 20 May 2025.
Profound Medical Corp.: what insiders have been doing
Every trade that managers of Profound Medical Corp. disclose to SEC (Form 4) is tracked on this page. The last twelve months, up to 18 October 2026, brought 64 filings signed by 13 insiders.
No insider sold shares on the market over the period. Instead, the filings list 2 purchases totalling €53k, made by 2 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €37k, bought by Fabian, Richard Ringler and made public on 17 September 2026 (0.020% of market cap). The buyers include 2 senior executives.
Compared with its exchange (5,808 companies, median 19 filings), a count of 64 filings is above the norm. Looking back to 2025, when coverage begins, insiders filed 3 purchases and no sales. The 10-K for the year ended 31 December 2025 shows 16.1 m USD of revenue and -42.6 m USD of net income.
The last purchase on record was published on 17 September 2026, which is 30 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. The legal deadline for a Form 4 is two business days after the transaction.
For comparison within the same market, see the insider buying recorded at GameStop Corp. and Heico Corp. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
65
Thresholds
n/a
Buy Volume
€91,538
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleMenawat Arun Swarup1 buy
Richard Ringler Fabian1 buy
Thomas Michael Tamberrino1 buy
Since the insiders bought
- +35.9%Entry US$5.13 · Close at T+365 US$6.97
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Profound Medical Corp. Strong Buy (bullish), based on 5 analysts. Average price target: US$11.14.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 20,010 of 24,148 companies
28.6
score / 100
Value12
Quality46
FCF yld-16%
Earn yld-18%
EV/EBITDA·
ROE-74%
Gross mgn71%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$6.62
Analyst consensus
5 analystsStrong buy
US$10.00Target US$11.14(+68%)US$12.00
Income statement
RevenueUS$16.1M
Gross profitUS$11.4M71% margin
EBITDA-US$40.7M-253% margin
Net income-US$42.6M-171.6% margin
Valuation
PER (forward)-11.3x
P/Book4.9x
Beta0.56
Balance sheet & cash
Market capUS$241.8M
Total debtUS$4.7M
Free Cash Flow-US$38.4M
Debt / Equity15%
Profitability & ownership
ROE-73.5%
ROA-39.5%
% insiders4.1%
% institutions45.0%
Last declaration on 24 September 2026
Declarations65 total
15,000 sharesRestricted Share UnitTSXSEDI:4781014
15,000 shares@ CA$9.76290.050% mcap93.4% of flowOptionsTSXSEDI:4781013
30,000 sharesRestricted Share UnitTSXSEDI:4781012
40,000 shares@ CA$9.76290.13% mcap76.2% of flowOptionsTSXSEDI:4781011
25,000 sharesRestricted Share UnitTSXSEDI:4781010
25,000 shares@ CA$9.76290.083% mcap64.3% of flowOptionsTSXSEDI:4781009
200,000 sharesRestricted Share UnitTSXSEDI:4781008
Restricted Share UnitTSXSEDI:4781007
475,000 shares@ CA$9.76291.57% mcap98.7% of flowOptionsTSXSEDI:4781006
OptionsTSXSEDI:4781005
100,000 sharesRestricted Share UnitTSXSEDI:4781003
200,000 shares@ CA$9.76290.66% mcap72.1% of flowOptionsTSXSEDI:4781001
10,000 shares@ CA$5.980.020% mcap1.3% of flowCommon SharesTSXSEDI:4778525
Canonical exit: 16 Dec 2026 (T+90)
Common SharesTSXSEDI:4778523
1,666 sharesDeferred Share UnitTSXSEDI:4775604
775 shares@ CA$9.390.0025% mcap27.5% of flowCommon SharesTSXSEDI:4775603
1,666 sharesDeferred Share UnitTSXSEDI:4775599
775 shares@ CA$9.390.0025% mcap27.5% of flowCommon SharesTSXSEDI:4775598
1,666 sharesDeferred Share UnitTSXSEDI:4775579
1,666 shares@ CA$9.390.0053% mcap44.9% of flowCommon SharesTSXSEDI:4775577
1,500 sharesRestricted Share UnitTSXSEDI:4775574
1,100 shares@ CA$9.390.0035% mcap6.6% of flowCommon SharesTSXSEDI:4775572
6,667 sharesRestricted Share UnitTSXSEDI:4775569
3,098 shares@ CA$9.390.0099% mcap7.7% of flowCommon SharesTSXSEDI:4775567
16,667 sharesRestricted Share UnitTSXSEDI:4775562
25 of 65 declarations
About Profound Medical Corp.
Profound Medical Corp. is a company focused on developing medical technologies for the treatment of prostate cancer. It specializes in using thermal energy to target and destroy tumor tissues.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
